ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "mycophenolate mofetil and pediatric rheumatology"

  • Abstract Number: 1394 • 2016 ACR/ARHP Annual Meeting

    A Pilot Study of Consensus Treatment Plans for Induction Therapy in Childhood Proliferative Lupus Nephritis

    Jennifer C. Cooper1, B. Anne Eberhard2, Marilynn Punaro3, Stacy P. Ardoin4, Hermine I. Brunner5, Joyce Hsu6, Linda Wagner-Weiner7, Kelly Rouster-Stevens8, Laura E. Schanberg9, Marisa Klein-Gitelman10, Emily von Scheven11 and CARRA Registry Investigators, 1Pediatrics, Divison of Rheumatology, University of California, San Francisco, San Francisco, CA, 2Cohen Children's Medical Center of New York, New Hyde Park, NY, 3Texas Scottish Rite Hospital for Children, Dallas, TX, 4Pediatric & Adult Rheumatology, Ohio State University, Columbus, OH, 5Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 6Pediatric Rheumatology, Stanford University, Palo Alto, CA, 7Pediatric Rheumatology, University of Chicago Hospitals, Chicago, IL, 8Pediatric Rheumatology, Emory University School of Medicine, Atlanta, GA, 9Pediatrics, Duke Medical Center, Durham, NC, 10Division of Rheumatology, Department of Pediatrics, Ann & Robert H. Lurie Children’s Hospital of Chicago/Northwestern University Feinberg School of Medicine, Chicago, IL, 11Division of Rheumatology, Department of Pediatrics, University of California, San Francisco, San Francisco, CA

    Background/Purpose:   Childhood-onset systemic lupus erythematous (cSLE) patients are at higher risk for renal disease than those with adult-onset disease. Mycophenolate mofetil (MMF) and intravenous…
  • Abstract Number: 1307 • 2014 ACR/ARHP Annual Meeting

    Monitoring of Mid-Interval Plasma Levels of Mycophenolic Acid in Pediatric Lupus Nephritis Patients

    Joyce S Hui-Yuen1, Kristi Truong2, Liza Mariel Bermudez-Santiago1, Amy J. Starr3, Andrew Eichenfield4, Lisa F. Imundo5 and Anca Askanase3, 1Morgan Stanley Children's Hospital of New York Presbyterian, Columbia University Medical Center, New York, NY, 2Doctor of Pharmacy degree program, St John's University, Queens, NY, 3Columbia University Medical Center, New York, NY, 4Div of Pediatric Rheumatology, Children's Hosp of New York, New York, NY, 5Assoociate Professor of Pediatrics in Medicine - Rheumatoology, Columbia University Medical Center, New York, NY

    Background/Purpose: Mycophenolate mofetil (MMF) is often used to treat lupus nephritis (LN) and extra-renal lupus in children with SLE. Plasma levels of mycophenolic acid (MPA)…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.